Dr Roslyn Brandon

Co-Founder, President and CEO of Immunexpress (IXP)
“Since an initial collaborative project in 2010, IXP has significantly increased its work with QFAB as a contract supplier of bioinformatics services. QFAB undertakes IXP’s genomics multivariate data analytical work – a critical foundation for the development of our novel clinical diagnostic products. IXP is leading the world in applying its patented immune system blood biomarkers to improving the management of sepsis patients and those at risk of sepsis. Sepsis is a life-threatening immune response to infection and is a leading cause of death in Intensive Care Units. QFAB works very effectively with our team to produce results time effectively and cost efficiently. The QFAB project team is a mainstay for our business as our product development processes rely heavily on world-class informatics. We have been very pleased with the quality and responsiveness of QFAB, and I am delighted to provide this testimonial for their client services.”